| Length (Minutes) |
7:30 AM |
Exhibits Open & Coffee Break |
| 10 |
8:00 AM |
Welcome & Introductions |
| |
| 20 |
8:10 AM |
Presentation of the CALTCM Excellence in Education Award |
| |
|
Award Recipient: Dolly Greene, RN, BSN, CIC |
| |
|
|
| 45 |
8:30 AM |
Substance Abuse, Alcohol, and Opioids |
| |
|
Speaker: Huy Ngo, MD |
| |
|
Learning Objectives: |
| |
|
1. Define substance use disorder criteria. |
| |
|
2. Outline facility responsibility for diagnosis and treatment of residents with substance use disorder. |
| |
|
3. Review a customized "substance use" care planning tool. |
| |
|
4. Practice motivational interviewing. |
| |
|
5. Get comfortable writing a prescription for buprenorphine. |
| |
|
|
| 45 |
9:15 AM |
New Drugs: A 2023 Update |
| |
|
Speaker: Janice Hoffman-Simen, Pharm.D., EdD, APh, BCGP, FASCP |
| |
|
Learning Objectives: |
| |
|
1. Identify trade and generic names of newly approved drugs in 2022-2023. |
| |
|
2. Describe the mechanism of action for three newly approved drugs and their black box warnings. |
| |
|
3. Differentiate newly approved drug agents that are appropriate for use in geriatrics. |
| |
|
|
| |
10:00 AM |
Break (30 minutes) |
| |
|
|
| 50 |
10:30 AM |
Beers Update |
| |
|
Speaker: Janice Hoffman-Simen, Pharm.D., EdD, APh, BCGP, FASCP and Aida Oganesyan, Pharm.D. |
| |
|
Learning Objectives: |
| |
|
1. Identify three differences with the new Beers criteria compared to the old criteria. |
| |
|
2. Define the patient population where the Beers criteria are the most important |
| |
|
3. Review a case of a patient who is utilizing Beers medications and identify strategies for deprescribing. |
| |
|
|
| 45 |
11:20 AM |
Are Illegal Drugs Good For the Elderly? Reviewing the "Fun" Drugs |
| |
|
Speaker: Cari Levy, MD |
| |
|
Learning Objectives: |
| |
|
1. Describe therapeutic indications and known effects of Ketamine, Psylocibin, and MDMA (Ecstasy).
|
| |
|
2. Review evidence of effectiveness of these drugs for depression, PTSD, and death anxiety. |
| |
|
3. Define micro-dosing and when it may be used. |
| |
|
4. Find a resource to test purity of a drug. |
| |
|
5. Develop comfort with asking questions about the use of these medications for your patients. |
| |
|
|
| |
12:05 PM |
Break/Exhibits |
| |
|
|
| |
12:15 PM |
Product Theater: (No CME) Lunch Break (45 Minutes) |
| |
|
|
| 10 |
1:10 PM |
Presentation of the CALTCM Poster Session Awards |
| |
|
|
| 45 |
1:20 PM |
Managing Parkinson's |
| |
|
Speaker: Indira Subramanian, MD |
| |
|
Learning Objectives: |
| |
|
1. Describe updates in Parkinson's disease treatments and how they may impact NH residents. |
| |
|
2. Describe a step wise, evidence-based plan, to treat Parkinson's disease. |
| |
|
3. Describe the major benefits and drawbacks of major drugs and how you may select a drug based on reducing polypharmacy. |
| |
|
|
| 5 |
2:05 PM |
In-The-Trenches / Topics and Speakers |
| |
|
1. "Recreational" or Therapeutic Use of Mind Altering Substances; Cari Levy; MD
2. Diabetes Management: Practice Makes Perfect; Mai-Khanh Nguyen, Pharm.D.
3. Ask a Neurologist about Parkinson's; Indira Subramanian, MD
4. Beers v. Beer in Nursing Homes; Janice Hoffman-Simen, Pharm.D., EdD, APh, BCGP, FASCP and Aida Oganesyan, Pharm.D.
5. Substance Use Disorder In PALTC; Huy Ngo, MD |
| |
|
|
| 40 |
2:10 PM |
In-The-Trenches Session (See topics & speakers noted above.) |
| |
|
|
| 30 |
2:50 PM |
Applying the Pearls from the 2023 CALTCM Summit for Excellence |
| |
|
|
| |
3:20 PM |
Adjourn |
